Amina Odidi

 

Company: IntelliPharmaCeutics

Position: President, COO and Co-Chief Scientific Officer

Industry: Pharmaceutical

Country: Canada

Dr. Amina Odidi is a founder and one of the principals of IntelliPharmaCeutics and serves as Director, President, Chief Operating Officer and Co-Chief Scientific Officer.

Since 1984 Dr. Amina Odidi has been a key player in the pharmaceutical industry by developing and applying proprietary technologies to the development of controlled-release drug products for third-party pharmaceutical companies.

Dr. Odidi received her B.Sc. degree in Pharmacy, from Ahmadu Bello University, and her M.Sc., Biopharmaceutics and Ph.D Pharmaceutics degrees from the University of London, England.

Dr. Odidi is an acclaimed scientist and innovator in the research, design, development and fabrication of controlled delivery technology platforms for sustained, timed, delayed, pulsatile or targeted delivery of pharmaceutical, nutraceutical, biological, chemical and agricultural materials in mammalian, terrestrial and extra-terrestrial environments. Dr. Odidi invented or co-invented various proprietary controlled delivery devices for the delivery of pharmaceutical, nutraceutical, biological, agricultural and chemical agents. She has held several senior management positions in the pharmaceutical and healthcare industries.

Dr. Odidi's role in the company is to oversee and assist in the development of key proprietary technology, from conception, through research and development, scale-up and manufacture, to clinical trials and regulatory approval. Dr. Amina Odidi will also provide strategic direction, managerial and scientific guidance. Professor Isa Odidi, together with Dr. Amina Odidi developed, between 1984 and 1995, the majority of the proprietary drug delivery technology used by IntelliPharmaCeutics for the production of controlled-release drug products. Dr. Amina Odidi continued this development from 1995 to date.


The Snowball: Warren Buffett and the Business of Life. The legendary Omaha investor has never written a memoir, but now he has allowed one writer, Alice Schroeder, unprecedented access to explore directly with him and with those closest to him his work, opinions, struggles, triumphs, follies, and wisdom. The result is the personally revealing and complete biography of the man known everywhere as “The Oracle of Omaha.” The second richest man in the world and most successful investor on the planet. Do yourself a favour and get this book. Take action, buy this book now.


If you like this article then please consider subscribing to our full feed RSS. You can also subscribe by Email and have new posts sent directly to your inbox. You can also subscribe by adding our feed to one of the following services by clicking on the appropriate buttons.


 digg.comgoogle.comYahooMyWeblive.comdel.icio.usask.comRedditstumbleupon.comTechnorati

Jay-z...And the Roc-a-fella Dynasty


William E. Powel

Company: General Motors Corporation (GM)

Position: Vice President, Industry-Dealer Affairs, North America

Industry: Automotive

Country: United States

Derek E. N. Saleeby

Company: RLJ Select Investments, LLC

Position: Executive Managing Director and Chief Investment Officer

Industry: Financial Services

Country: United States

Robin Wilson

Company: Robin Wilson Home

Position: CEO

Industry: Design Services

Country: United States

Ronald A. Williams

Company: Aetna Inc.

Position: CEO/President

Industry: Health Care

Country: United States

Eunice Mosley Dudley

Company: Dudley Products, Inc.

Position: Co-Founder, CFO

Industry: Cosmetics

Country: United States